Literature DB >> 7541307

Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells.

I Correa1, D H Raulet.   

Abstract

Class I MHC expression by target cells inhibits lysis mediated by natural killer (NK) cells, often in an allele-specific fashion. It has been proposed that NK cell inhibitory receptors recognize complexes of class I molecules with specific cellular peptides that define self, displacement of which would render cells NK sensitive. By loading the mostly empty Dd class I molecules of cell lines deficient in peptide transporter molecules with synthetic or natural Dd-bound peptides, we have demonstrated specific dose-dependent inhibition of the Ly49+ subset of activated NK cells by class I-peptide complexes. Inhibition occurred with most if not all Dd-binding peptides, suggesting that Ly49+ NK cells recognize class I-peptide complexes largely independently of peptide composition. The results suggest a primary role of NK cells in the destruction of cells that have down-regulated or extinguished cell surface expression of some or all class I molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541307     DOI: 10.1016/1074-7613(95)90079-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  36 in total

Review 1.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.

Authors:  C Perreault; J Jutras; D C Roy; J G Filep; S Brochu
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Vahid Khalilzad-Sharghi; Zhongji Han; Shadi Othman; David Steffen; Jay Reddy
Journal:  Int J Cardiol       Date:  2015-09-18       Impact factor: 4.164

4.  Using a baculovirus display library to identify MHC class I mimotopes.

Authors:  Yibing Wang; Anatoyla Rubtsov; Ryan Heiser; Janice White; Frances Crawford; Philippa Marrack; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

Review 5.  Cis interactions of immunoreceptors with MHC and non-MHC ligands.

Authors:  Werner Held; Roy A Mariuzza
Journal:  Nat Rev Immunol       Date:  2008-02-29       Impact factor: 53.106

6.  HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one.

Authors:  W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

7.  Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.

Authors:  F Zappacosta; F Borrego; A G Brooks; K C Parker; J E Coligan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

8.  Self and viral peptides can initiate lysis by autologous natural killer cells.

Authors:  O Mandelboim; S B Wilson; M Valés-Gómez; H T Reyburn; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.

Authors:  O Ayalon; E A Hughes; P Cresswell; J Lee; L O'Donnell; R Pardi; J R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

10.  Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented.

Authors:  Nathalie Escande-Beillard; Lorraine Washburn; Dan Zekzer; Zhongqi-Phyllis Wu; Shoshy Eitan; Sonja Ivkovic; Yuxin Lu; Hoa Dang; Blake Middleton; Tina V Bilousova; Yoshitaka Yoshimura; Christopher J Evans; Sebastian Joyce; Jide Tian; Daniel L Kaufman
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.